Clinical Cancer Research Versailles No Abst Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitadai, Y.
Right arrow Articles by Tahara, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitadai, Y.
Right arrow Articles by Tahara, E.
Clinical Cancer Research Vol. 6, 2735-2740, July 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Regulation of Disease-Progression Genes in Human Gastric Carcinoma Cells by Interleukin 81

Yasuhiko Kitadai2, Ken Haruma, Naofumi Mukaida, Yasukazu Ohmoto, Norimasa Matsutani, Wataru Yasui, Shigeru Yamamoto, Koji Sumii, Goro Kajiyama, Isaiah J. Fidler and Eiichi Tahara

First Departments of Internal Medicine [Y. K., K. H., N. M., S. Y., K. S., G. K.] and Pathology [W. Y., E. T.], Hiroshima University School of Medicine, Hiroshima 734-8551, Japan; Department of Molecular Oncology, Cancer Research Institute, Kanazawa University, Kanazawa 920-0934, Japan [N. M.]; Cellular Technology Institute, Otsuka Pharmaceutical Company, Ltd., Tokushima 771-01, Japan [Y. O.]; and Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [I. J. F.]

The expression of interleukin 8 (IL-8) by human gastric carcinomas directly correlates with tumor vascularity and disease progression. To determine whether IL-8 can act in an autocrine manner to regulate the expression of other disease-progression genes, we examined the expression of IL-8 receptors IL-8RA (CXCR1) and IL-8RB (CXCR2) in six different human gastric carcinoma cell lines and 38 surgical specimens of human gastric carcinomas. All of the gastric carcinoma cell lines expressed mRNA and protein for IL-8RA and IL-8RB protein. In all surgical specimens, the majority of the tumor cells and small vessel endothelial cells stained positive for IL-8RA and IL-8RB protein. In vitro treatment of human gastric cancer MKN-1 cells with exogenous IL-8 enhanced the expression of epidermal growth factor receptor, type IV collagenase (metalloproteinase-9), vascular endothelial growth factor, and IL-8 mRNA. In contrast, treatment with exogenous IL-8 decreased expression of E-cadherin mRNA. IL-8 treatment increased invasive capacity of MKN-1 cells, which was associated with activity of metalloproteinase-9. Collectively, these results demonstrate that human gastric carcinoma cells express receptors for IL-8 and that IL-8 may play a role in the progressive growth of human gastric carcinoma by autocrine/paracrine mechanisms.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
C. R. Amura, K. S. Brodsky, B. Gitomer, K. McFann, G. Lazennec, M. T. Nichols, A. Jani, R. W. Schrier, and R. Brian Doctor
CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation
Am J Physiol Cell Physiol, March 1, 2008; 294(3): C786 - C796.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B.-R. Lin, C.-C. Chang, L.-R. Chen, M.-H. Wu, M.-Y. Wang, I-H. Kuo, C.-Y. Chu, K.-J. Chang, P.-H. Lee, W.-J. Chen, et al.
Cysteine-Rich 61 (CCN1) Enhances Chemotactic Migration, Transendothelial Cell Migration, and Intravasation by Concomitantly Up-Regulating Chemokine Receptor 1 and 2
Mol. Cancer Res., November 1, 2007; 5(11): 1111 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Wang, D. T. Hendricks, F. Wamunyokoli, and M. I. Parker
A Growth-Related Oncogene/CXC Chemokine Receptor 2 Autocrine Loop Contributes to Cellular Proliferation in Esophageal Cancer.
Cancer Res., March 15, 2006; 66(6): 3071 - 3077.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Savage, L. Hou, J. Lissowska, W.-H. Chow, W. Zatonski, S. J. Chanock, and M. Yeager
Interleukin-8 polymorphisms are not associated with gastric cancer risk in a polish population.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 589 - 591.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Taguchi, N. Ohmiya, K. Shirai, N. Mabuchi, A. Itoh, Y. Hirooka, Y. Niwa, and H. Goto
Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2487 - 2493.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W.-P. Lee, D.-I. Tai, K.-H. Lan, A. F.-Y. Li, H.-C. Hsu, E.-J. Lin, Y.-P. Lin, M.-L. Sheu, C.-P. Li, F.-Y. Chang, et al.
The -251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population
Clin. Cancer Res., September 15, 2005; 11(18): 6431 - 6441.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Savage, C. C. Abnet, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock
Variants of the IL8 and IL8RB Genes and Risk for Gastric Cardia Adenocarcinoma and Esophageal Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Mukaida
Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases
Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L566 - L577.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Lu, Y. Nakamoto, Y. Nemoto-Sasaki, C. Fujii, H. Wang, M. Hashii, Y. Ohmoto, S. Kaneko, K. Kobayashi, and N. Mukaida
Potential Interaction between CCR1 and Its Ligand, CCL3, Induced by Endogenously Produced Interleukin-1 in Human Hepatomas
Am. J. Pathol., April 1, 2003; 162(4): 1249 - 1258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.